Searched for
PHARMA VENDORS
Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...- Gold stocks still overvalued despite market correction: Aditya ShahIndian markets experienced volatility as geopolitical tensions and rising fuel prices fueled investor caution, leading to a shift towards d...
- SUSE eyes deeper India push as CEO flags growth, open-source demandSUSE plans to increase investments in India, recognizing it as a significant growth market for open-source technologies. The company aims t...
- Small pharma companies seek price caps on inputs as costs surgeIndian pharmaceutical units face a severe crisis. Input costs have surged by 200-300 percent. This is due to global conflicts disrupting ra...
- How will Biosecure Act impact Indian pharma companies? Aditya Khemka explainsWe own a stock here called Jubilant Pharmova. The company was given a grant from the US government to create a manufacturing facility on th...
- How Glenmark, Gland Pharma are reducing carbon emissions & increasing supply chain transparencyWith increased focus on sustainability, the domestic pharma firms are advancing their energy efficiency throughout their operational spectr...
- PLI scheme: Govt frames process for streamlining visa approvals for Chinese professionalsSome players had flagged the visa issue in a stakeholder consultation meeting on the production-linked incentive (PLI) scheme in August.
- Biocon signs up with external law firm to review governance process at vendor firms"The company already has a strong code of conduct and an anti-bribery and anti-corruption clause in its contracts with all its vendors. The...
- We’re just aggregators, e-pharmacies tell Madras High CourtThis comes after the Madras High Court, in a recent injunction, restrained unlicenced e-pharmacies from doing business.
- Drug companies fear double tax on old stocksUnder the current law, pharmaceutical companies that have stock lying with them that is older than 12 months are not entitled to a set off ...
- Pharma companies to vendors: Be GST-ready to avoid delay in paymentsMany manufactures who undertake production for Indian as well as multinational drug majors are rushing to put GST infrastructure in place.
- US Justice Deptt charge against pharma cos a serious charge: Surajit Paul, Prabhudas Lilladher“In Sun-Taro’s case, they pushed up the price because there was not much competition or suppliers.”
- Indian healthcare BPOs facing competition from US, PhilippinesThe Philippines and other low-cost locations are emerging as a big challenge to Indian BPO industry including the healthcare vertical.
- Sanofi, Novartis and GSK in race to buy Elder Pharma's domestic formulations businessSanofi, Novartis and GSK are in the race to buy out the domestic formulations business of debt-ridden Elder Pharmaceuticals.
- Elder Pharma rallies 5% on stake sale reportsAt 09:20 a.m.; Elder Pharma was locked in 5 per cent upper circuit at Rs 357.15. It hit a low of Rs 347.70 in trade today.
- Debt-ridden Elder Pharmaceuticals on the blockPromoters’ move to sell drug maker evokes interest from India’s large pharma companies and MNCs keen on gaining access to its three brands.
- HCL Technologies inks multi-year deal with Purdue PharmaThe scope of this engagement covers management of two data centers and all remote locations of the client in the US, HCL Technologies said.
- Genpact extends portfolio, to help clients cut costsBPO firm Genpact is extending its service portfolio beyond traditional services by trimming expense bills and increasing cash flows for cli...
- 'Telcos should emulate FMCG's distribution in rural areas'A robust distribution system similar to that of FMCG companies' will be crucial for the success of both handset vendors and operators in ru...
- The Road AheadThe panel members as well as the audience in Mumbai had an interesting debate on VAT in the ETIG Knowledge Forum on 'VAT.
Load More
